This is the COVID-19 programme initiator and will set the scene: why this programme; main outcomes; FIP advocacy role. It aligns with 800 days since pandemic and will launch SustainabilityRx website/ Visualisation (FIP’s response to COVID-19) with a focus on pandemic preparedness.

Aim
To update attendees on the current COVID-19 situation from the perspectives of pharmaceutical science, pharmacy practice and workforce/education and discuss what needs to be done to prepare for future pandemics.

Learning objectives
1. Describe the functionality of the SustainabilityRx website
2. Outline the current COVID-19 situation from the perspectives of practice, science and workforce/education;
3. Consider steps that can be taken to prepare for future pandemics.

Moderators:
-Christopher John, FIP Lead for Data and Intelligence
FIP - UK
-Dr Lina Bader/Dr Sherly Meilianti FIP Lead for Workforce Transformation/FIP Data and Intelligence Specialist, FIP-Saudi Arabia

Panelists:
-Dr Hoai-An Truong, Professor and Director of Public Health, School of Pharmacy & Health Professions, University of Maryland, USA
-Dr John Grabenstein, Member of FIP COVID-19 Expert Advisory Group, President Vaccine Dynamics SP -
USA
-Prof. Trevor Jones, Visiting Professor King’s College London-UK
-Dr Ally Dering-Anderson, Current member of the FIP COVID-19 Expert Advisory Groupm, Clinical Associate Professor in the Department of Pharmacy Practice & Science University of Nebraska College of Pharmacy-
USA
-Shaun Gleason, FIP Hub DG1 Lead
Member of the COVID-19 Expert Advisory Group
Assistant Dean for Distance Degrees and Programs; Associate Professor, Skaggs School of Pharmacy and Pharmaceutical Sciences University of Colorado Anschutz Medical Campus-USA

свернуть